Evidence map›Paper›PMID 29450689›Full record

Trial reportHeart and vessels2018

The first multicenter, randomized, controlled trial of home telemonitoring for Japanese patients with heart failure: home telemonitoring study for patients with heart failure (HOMES-HF).

Norihiko Kotooka, Masafumi Kitakaze, Kengo Nagashima, Machiko Asaka, Yoshiharu Kinugasa, Kotaro Nochioka, Atsushi Mizuno, Daisuke Nagatomo, Daigo Mine, Yoko Yamada and 21 more

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Heart and vessels, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04466852 (Otimização do Sistema de Saúde no Brasil Com Telemedicina), which is not on this map. Cited by 38 papers, 16 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 16 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04466852 narecruitingnot on this mapstarted 2020, after this paper: background citation

Otimização do Sistema de Saúde no Brasil Com Telemedicina

TypeinterventionalSponsorUniversity Hospital Bispebjerg and FrederiksbergRan2020 to 2025Enrolled720ConditionsHeart FailureArmstelemedicine-guided consultation
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 16 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Norihiko KotookaDepartment of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga, Saga, 849-8501, Japan. kotooka@cc.saga-u.ac.jp.
Masafumi KitakazeDepartment of Clinical Medicine and Development, National Cerebral and Cardiovascular Center, Suita, Japan.
Kengo NagashimaDepartment of Clinical Research, Graduate School of Medicine, Chiba University, Chiba, Japan.
Machiko AsakaDepartment of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga, Saga, 849-8501, Japan.
Yoshiharu KinugasaDivision of Cardiovascular Medicine, Department of Molecular Medicine and Therapeutics, Tottori University, Yonago, Japan.
Kotaro NochiokaDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Atsushi MizunoDepartment of Cardiology, St. Luke's International Hospital, Tokyo, Japan.
Daisuke NagatomoDepartment of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga, Saga, 849-8501, Japan.
Daigo MineDepartment of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga, Saga, 849-8501, Japan.
Yoko YamadaDivision of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Omiya, Japan.
Akiko KuratomiKoga Hospital 21, Kurume, Japan.
Norihiro OkadaDepartment of Cardiology and Clinical Examination, Oita University, Oita, Japan.
Daisuke FujimatsuSaiseikai Karatsu Hospital, Karatsu, Japan.
So KuwahataTarumizu Municipal Medical Center, Tarumizu Chuo Hospital, Tarumizu, Japan.
Shigeru ToyodaDepartment of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan.
Shin-Ichi HirotaniCardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Takahiro KomoriDepartment of Medicine, Division of Cardiovascular Medicine, Jichi Medical University, Shimotsuke, Japan.
Kazuo EguchiDepartment of Medicine, Division of Cardiovascular Medicine, Jichi Medical University, Shimotsuke, Japan.
Kazuomi KarioDepartment of Medicine, Division of Cardiovascular Medicine, Jichi Medical University, Shimotsuke, Japan.
Takayuki InomataDepartment of Cardiovascular Medicine, Kitasato Institute Hospital, Tokyo, Japan.
Kaoru SugiToho University Ohashi Medical Center, Tokyo, Japan.
Kazuhiro YamamotoDivision of Cardiovascular Medicine, Department of Molecular Medicine and Therapeutics, Tottori University, Yonago, Japan.
Hiroyuki TsutsuiDepartment of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Tohru MasuyamaCardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Hiroaki ShimokawaDepartment of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Shin-Ichi MomomuraDivision of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Omiya, Japan.
Yoshihiko SeinoDepartment of Cardiology, Nippon Medical School Chiba-Hokusoh Hospital, Inzai, Japan.
Yasunori SatoDepartment of Clinical Research, Graduate School of Medicine, Chiba University, Chiba, Japan.
Teruo InoueDepartment of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan.
Koichi NodeDepartment of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga, Saga, 849-8501, Japan.
HOMES-HF study investigators

Funding

Japanese Ministry of Health, Labor, and Welfare Comprehensive Research on AgingJapanese Ministry of Health, Labor, and Welfare Health (KR23000003)Japanese Ministry of Health, Labor, and Welfare Health (KR24000001)Japan Society for the Promotion of Science KAKENHI JP17K09510
6 · The paper itself

Abstract

Home telemonitoring is becoming more important to home medical care for patients with heart failure. Since there are no data on home telemonitoring for Japanese patients with heart failure, we investigated its effect on cardiovascular outcomes. The HOMES-HF study was the first multicenter, open-label, randomized, controlled trial (RCT) to elucidate the effectiveness of home telemonitoring of physiological data, such as body weight, blood pressure, and pulse rate, for Japanese patients with heart failure (UMIN Clinical Trials Registry 000006839). The primary end-point was a composite of all-cause death or rehospitalization due to worsening heart failure. We analyzed 181 recently hospitalized patients with heart failure who were randomly assigned to a telemonitoring group (n = 90) or a usual care group (n = 91). The mean follow-up period was 15 (range 0-31) months. There was no statistically significant difference in the primary end-point between groups [hazard ratio (HR), 0.95; 95% confidence interval (CI), 0.548-1.648; p = 0.572]. Home telemonitoring for Japanese patients with heart failure was feasible; however, beneficial effects in addition to those of usual care were not demonstrated. Further investigation of more patients with severe heart failure, participation of home medical care providers, and use of a more integrated home telemonitoring system emphasizing communication as well as monitoring of symptoms and physiological data are required.

Indexed as

Disease ManagementHome Care ServicesAgedFemaleFollow-Up StudiesHeart FailureHemodynamicsHumansJapanMaleMonitoring, PhysiologicMorbidityProspective StudiesTelemedicineDisease managementHeart failureHome healthcareMultidisciplinaryTelemonitoring

Identifiers

PMID29450689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.